NCT00001311.

Methods	Randomized controlled trial
Participants	People with uveitis who required cataract surgery; free of active inflammation for at least 3 months
Interventions	People randomly assigned to receive a standard IOL or heparin surface modified IOL
Outcomes	Periodic follow-up visits for about 1 year may have included: fluorescein angiography to evaluate the blood vessels of the retina; specular microscopy to examine the surface of the IOL; cell and flare measurements to evaluate inflammation, and ultrasound to examine the back of the eye
Notes	Sponsor: National Eye Institute (NEI) intramural research (Study ID: 92-EI-0157) ClinicalTrials.gov Identifier: NCT00001311 We contacted the Office of Communication, Health Education, and Public Liaison at NEI for information about the study. NEI replied via email that the principal investigator on the trial, Dr. Scott Whitcup, left the NEI. Our attempts to contact Dr. Scott Whitcup did not yield further information

IOL: intraocular lens.